Pfizer to provide U.S. government with 10 million treatment courses of oral antiviral Covid-19 drug
November 18, 2021 – Pfizer Inc. announced an agreement with the U.S. government to supply 10 million treatment courses of its investigational COVID-19 oral antiviral…